These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9785162)

  • 1. Perceived contraindications to thrombolytic treatment in acute myocardial infarction. A survey at a teaching hospital.
    Wald DS
    J Accid Emerg Med; 1998 Sep; 15(5):329-31. PubMed ID: 9785162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of thrombolysis for acute myocardial infarction in the presence of diabetic retinopathy in the UK, and associated ocular haemorrhagic complications.
    Higgs ER; Parfitt VJ; Harney BA; Hartog M
    Diabet Med; 1995 May; 12(5):426-8. PubMed ID: 7648806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolytic treatment for myocardial infarction: an examination of practice in 39 United Kingdom hospitals. Myocardial Infarction Audit Group.
    Birkhead JS
    Heart; 1997 Jul; 78(1):28-33. PubMed ID: 9290398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction.
    French JK; Williams BF; Hart HH; Wyatt S; Poole JE; Ingram C; Ellis CJ; Williams MG; White HD
    BMJ; 1996 Jun; 312(7047):1637-41. PubMed ID: 8664716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential influence of previous medical pathology on use of thrombolysis in the elderly with suspected acute myocardial infarction.
    Arino S; Bayer A
    Gerontology; 1993; 39(1):33-7. PubMed ID: 8440488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rural Alberta thrombolysis study. Survey of practice patterns for managing acute myocardial infarction.
    Hindle H; Norheim JK; Renger R
    Can Fam Physician; 1995 Jul; 41():1180-7. PubMed ID: 7647623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wide variation in the use of thrombolytic therapy among junior doctors in south and central Scotland.
    Hood S; Birnie D; Curzio JL; Hillis WS
    Health Bull (Edinb); 1996 Mar; 54(2):131-9. PubMed ID: 8655300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Withholding thrombolysis in patients with diabetes mellitus and acute myocardial infarction.
    Shotliff K; Kaushal R; Dove D; Nussey SS
    Diabet Med; 1998 Dec; 15(12):1028-30. PubMed ID: 9868976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suspected myocardial infarction and left bundle branch block: electrocardiographic indicators of acute ischaemia.
    Edhouse JA; Sakr M; Angus J; Morris FP
    J Accid Emerg Med; 1999 Sep; 16(5):331-5. PubMed ID: 10505911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation, delay, and contraindication to thrombolytic treatment in females and males with myocardial infarction.
    Grace SL; Abbey SE; Bisaillon S; Shnek ZM; Irvine J; Stewart DE
    Womens Health Issues; 2003; 13(6):214-21. PubMed ID: 14675790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed thrombolytic treatment of older patients with acute myocardial infarction.
    McLaughlin TJ; Gurwitz JH; Willison DJ; Gao X; Soumerai SB
    J Am Geriatr Soc; 1999 Oct; 47(10):1222-8. PubMed ID: 10522956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection factors for the use of thrombolytic treatment in acute myocardial infarction: a population based study of current practice in the United Kingdom. The European Secondary Prevention Study Group.
    Ketley D; Woods KL
    Br Heart J; 1995 Sep; 74(3):224-8. PubMed ID: 7547014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolysis in acute myocardial infarction following prolonged cardiopulmonary resuscitation.
    Merriman CS; Kalbfleisch ND
    Acad Emerg Med; 1994; 1(1):61-6. PubMed ID: 7621155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contraindications of thrombolytic therapy in acute myocardial infarct].
    Genoni M; Malacrida R; Maggioni A; Moccetti T
    Z Kardiol; 1996 Jun; 85(6):397-406. PubMed ID: 8767364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of overutilization and underutilization of thrombolytic therapy in clinical practice. TRACE Study Group. TRAndolapril Cardiac Evaluation.
    Ottesen MM; Køber L; Jørgensen S; Torp-Pedersen C
    J Am Coll Cardiol; 2001 May; 37(6):1581-7. PubMed ID: 11345368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of clinical trial results in myocardial infarction to medical practice: comparison of four year outcome in participants of a thrombolytic trial, patients receiving routine thrombolysis, and those deemed ineligible for thrombolysis.
    Brown N; Melville M; Gray D; Young T; Skene AM; Wilcox RG; Hampton JR
    Heart; 1999 Jun; 81(6):598-602. PubMed ID: 10336917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction.
    Ketley D; Woods KL
    Lancet; 1993 Oct; 342(8876):891-4. PubMed ID: 8105166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolytic therapy of acute myocardial infarction. Keeping the unfulfilled promises.
    Doorey AJ; Michelson EL; Topol EJ
    JAMA; 1992 Dec; 268(21):3108-14. PubMed ID: 1433742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of patients with acute myocardial infarction for thrombolytic therapy.
    Muller DW; Topol EJ
    Ann Intern Med; 1990 Dec; 113(12):949-60. PubMed ID: 2240919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [What thrombolytic rate can be realized in acute myocardial infarct? Results of the Oltner Heart Emergency Study].
    Gaillet R; Saner H; Pfister R; Pirovino M
    Schweiz Med Wochenschr; 1998 May; 128(20):775-83. PubMed ID: 9642753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.